dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Herrero, Carolina |
dc.contributor.author | Brea, Jose |
dc.contributor.author | Pérez-Díaz, Amparo |
dc.contributor.author | Cuadrado, Emiliano |
dc.contributor.author | Ferreño, Noelia |
dc.contributor.author | Moiola, Cristian Pablo |
dc.contributor.author | Colas Ortega, Eva |
dc.contributor.author | Gil Moreno, Antonio |
dc.date.accessioned | 2022-01-20T14:52:05Z |
dc.date.available | 2022-01-20T14:52:05Z |
dc.date.issued | 2021-08-01 |
dc.identifier.citation | Herrero C, Brea J, Pérez-Díaz A, Cuadrado E, Ferreño N, Moiola CP, et al. Modeling ANXA2-overexpressing circulating tumor cells homing and high throughput screening for metastasis impairment in endometrial carcinomas. Biomed Pharmacother. 2021 Aug 1;140:111744. |
dc.identifier.issn | 0753-3322 |
dc.identifier.uri | https://hdl.handle.net/11351/6855 |
dc.description | Cèl·lules tumorals circulants; Micrometàstasi; Daunorrubicina |
dc.description.sponsorship | This work was supported by grants from the Instituto de Salud Carlos III ( ISCIII ), grant PI17/01919 and PI20/00969 , co-financed by the European Regional Development Fund (FEDER); from Fundación Científica de la Asociación Española Contra el Cáncer (AECC), Grupos Clínicos Coordinados 2018; Xunta de Galicia ( ED431C 2018/21 ); Ministry of Economy and Competiveness (Innopharma Project) and from CIBERONC ( CB16/12/00328 ); Carolina Herrero is supported by a predoctoral i-PFIS fellowship from Instituto de Salud Carlos III ( IFI17/00047 ). |
dc.language.iso | eng |
dc.publisher | Elsevier |
dc.relation.ispartofseries | Biomedicine & Pharmacotherapy;140 |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ |
dc.source | Scientia |
dc.subject | Endometri - Càncer - Tractament |
dc.subject | Cèl·lules canceroses |
dc.subject.mesh | Endometrial Neoplasms |
dc.subject.mesh | /drug therapy |
dc.subject.mesh | Neoplastic Cells, Circulating |
dc.title | Modeling ANXA2-overexpressing circulating tumor cells homing and high throughput screening for metastasis impairment in endometrial carcinomas |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1016/j.biopha.2021.111744 |
dc.subject.decs | neoplasias endometriales |
dc.subject.decs | /farmacoterapia |
dc.subject.decs | células neoplásicas circulantes |
dc.relation.publishversion | https://doi.org/10.1016/j.biopha.2021.111744 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Herrero C, Ferreño N] Translational Medical Oncology Group (Oncomet), Health Research Institute of Santiago de Compostela (IDIS), University Hospital of Santiago de Compostela (SERGAS), Santiago de Compostela, Spain. [Brea J, Pérez-Díaz A, Cuadrado E] Drug Screening Platform/Biofarma Research Group, Centro Singular de Investigación en Medicina Molecular y Enfermedades Crónicas (CIMUS), Universidade de Santiago de Compostela, Santiago de Compostela, Spain. [Moiola CP] Grup de Recerca Biomèdica en Ginecologia, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. [Colás E, Gil-Moreno A] Grup de Recerca Biomèdica en Ginecologia, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain |
dc.identifier.pmid | 34049223 |
dc.identifier.wos | 000670106300001 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |